Quantification of hepatitis C virus by TaqMan PCR: Comparison with HCV amplicor monitor assay
- 3 May 1999
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 58 (2), 121-126
- https://doi.org/10.1002/(sici)1096-9071(199906)58:2<121::aid-jmv4>3.0.co;2-4
Abstract
The quantitation of serum levels of hepatitis C virus RNA in chronic hepatitis C has been regarded as one of the most important indicators for the outcome of interferon therapy. A new method was used for quantitating the copy number of hepatitis C virus RNA using TaqMan polymerase chain reaction and for comparing the ability and usefulness of this assay with Amplicor Monitor assay in 138 patients. The detection range of hepatitis C virus RNA by TaqMan polymerase chain reaction was from 2 × 103 to 2 × 108 copies/ml. Hepatitis C virus RNA was detectable in 128 cases (92.8%) and undetectable in 10 cases (7.2%) by this method. The RNA levels measured by Amplicor Monitor assay correlated significantly with those measured by TaqMan polymerase chain reaction assay and the sensitivity of the two assays was almost equal. Thus, TaqMan polymerase chain reaction assay appears sufficiently sensitive for the evaluation of hepatitis C virus RNA and would be useful for the diagnosis and management of hepatitis C virus infection. J. Med. Virol. 58:121–126, 1999.Keywords
This publication has 18 references indexed in Scilit:
- A novel method for real time quantitative RT-PCR.Genome Research, 1996
- Real time quantitative PCR.Genome Research, 1996
- Significance of specific antibody assay for genotyping of hepatitis C virusHepatology, 1994
- Significance of serum hepatitis C virus RNA levels in chronic hepatitis CThe Lancet, 1993
- Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversityJournal of General Virology, 1993
- Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction.Journal of Clinical Investigation, 1990
- Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactionsGene, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989